Healthcare

This bill reauthorizes federal grant programs supporting telehealth networks and resource centers through the Public Health Service Act. It provides $42.05 million annually for fiscal years 2026 through 2030 to fund these programs. The key provision is the specific, multi-year funding amount for existing telehealth infrastructure and support services. These grants directly support healthcare providers and community organizations that expand remote medical services. The bill makes no changes to program eligibility or structure, only extending funding authorization.

HR 2810, the Family Cord Blood Banking Act, allows individuals to deduct payments for private umbilical cord blood or tissue banking as medical expenses on their federal taxes. It directly affects people who pay for these private banking services through accredited providers meeting specific federal safety standards. The bill amends the tax code to add private cord banking services as a qualifying medical expense, effective for tax years starting after December 31, 2024. This change simplifies tax treatment for those using private cord banking without altering insurance coverage or public banking access.

HR 6668, the Clean Water Standards for PFAS Act of 2025, establishes federal limits on PFAS chemicals in water. It requires the EPA to set water quality standards for PFAS by 2026 and create discharge limits for specific industries (like chemical manufacturing, electroplating, and landfills) by 2026-2028. The bill mandates immediate monitoring of PFAS discharges from these industries and public treatment plants, and funds $200 million annually (2026-2030) to help treatment works address PFAS contamination. It also requires the EPA to adopt a new testing method for PFAS by January 2026.

This bill would revoke the tax-exempt status of nonprofit organizations (like charities or health groups) that provide or fund abortions, except in specific cases. It directly affects organizations currently classified under Section 501(c)(3) of the tax code, such as some healthcare providers or advocacy groups. Key provisions define "abortion" as intentionally terminating a pregnancy (excluding cases where the mother’s life is at risk, or the pregnancy resulted from rape or incest), and deny tax exemption to groups meeting this definition. The change would take effect for tax years starting after the bill’s enactment date.

HR 7173, the Follow the Science Act, restricts political appointees from influencing National Institutes of Health (NIH) operations and grant decisions. It prohibits most political appointees (defined broadly as those in policy-making roles) from being employed by NIH or participating in grant reviews, funding selections, or policy implementation. The bill requires the NIH Director to report on past political appointee involvement in these activities to Congress within 30 days of enactment. These changes aim to ensure NIH decisions are based on scientific merit rather than political influence, with limited exceptions for other federal agencies.

This bill requires the Department of Defense to assign mental health professionals with necessary security clearances to all Cyber Command duty locations by 2025. It directly affects Cyber Mission Force personnel by ensuring they have access to cleared providers for treatment of work-related stress and behavioral health challenges. Key provisions mandate annual congressional briefings on implementation progress, clearance validation, clinical workload, and efforts to increase awareness of available mental health services. The law focuses on improving access to care through staffing requirements and transparency, without altering existing benefits or funding mechanisms.

This bill (HR 5467, the PAAT Act) requires Medicare Part D plans to cover specific drugs treating autoimmune diseases, hemophilia, and Von Willebrand disease starting in 2027. It directly affects Medicare beneficiaries with these conditions by mandating plan coverage for relevant medications. Key provisions include requiring plans to include all covered drugs for these conditions and prohibiting prior authorization for such drugs more than once per year, unless the drug is short-term, a controlled substance, or has a risk management strategy. The law aims to reduce coverage barriers for these treatments without altering drug approval or pricing.

HR 3749, the HER Act, directs the U.S. Department of Health and Human Services to fund research on how endocrine-disrupting chemicals (chemicals that interfere with hormones) in personal care products affect women’s reproductive health. It provides federal grants for scientific research and requires states to receive funding for investigating these chemicals and running public awareness campaigns about safer alternatives. Every five years, the Department must publish reports detailing research findings, listing safe/harmful products, and suggesting ways to expand FDA regulation of harmful ingredients. This bill directly affects women’s health researchers, state health agencies, and consumers seeking safer personal care products, while aiming to inform future regulatory action.

Radiation Oncology Case Rate Value Based Program Act of 2025 or the ROCR Value Based Program Act This bill establishes a specialized payment program under Medicare for providers and suppliers of radiation oncology services.  Specifically, the Centers for Medicare & Medicaid Services (CMS) must establish a program under which radiation therapy providers (i.e., hospital outpatient departments) and suppliers (i.e., physician group practices and freestanding radiation therapy centers) receive payments for each episode of care provided to individuals with specified types of cancer. An episode of care  means the period beginning on the day radiation therapy planning is furnished to the individual and ending (1) for individuals with bone or brain metastases, 30 days later; and (2) for individuals with other cancer types, 90 days later. Participation in the program is mandatory for providers and suppliers that participate in Medicare, unless the provider or supplier is part of a state-based Center for Medicare & Medicaid Innovation model or qualifies for a significant hardship exemption. The CMS must set payment rates for the program based on national payment rates with specified adjustments (e.g., geographic adjustments). Providers and suppliers who provide certain transportation services for individuals under their care may receive an additional payment. Providers and suppliers must be accredited in accordance with certain standards, subject to payment reductions. The Government Accountability Office must report on (1) implementation of the program, and (2) underserved areas that are in need of more or newer radiation therapy resources.

HR 6848, the Whole Health for Veterans Act, eliminates copayments for Whole Health well-being services provided by the Department of Veterans Affairs (VA). The bill requires the VA to cover these services - such as wellness coaching, meditation, yoga, and skill-building courses - without out-of-pocket costs for most veterans, with a maximum $30 monthly copayment allowed for some. Priority groups 1-5 (veterans already exempt under current policy) remain fully exempt, while other veterans may face the $30 cap. This policy change directly affects all VA-enrolled veterans seeking these non-medical wellness services.